$20 million seems like a FAIR, but still extremely low, VALUATION for the company that has a CoronaVirus treatment/vaccine coming down the FDA FAST TRACK pike...! :)
Then they have their Adva-27a anti-Cancer drug trials coming... Cleaned up their debt...doing this before the CoronaVirus came knocking...
SBFM, undervalued even at $20 million market cap! 8¢! 10x that! 80¢! 100x! Lol...